Latest Organic chemistry Stories
RALEIGH, N.C., Feb. 27, 2013 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) today announced that the Company will host "Treatment of Pain and Opioid Dependence with Buprenorphine" for investors and analysts on Thursday, March 7, 2013 at 12:00 pm, in New York City. This event will include insightful discussion from medical experts with extensive experience in the management of chronic pain and opioid dependence using various formulations of buprenorphine,...
1-Day Only Amazon.com 50% OFF Sale on All-New NatureWise Raspberry Ketones Plus+ - Wednesday, February 27 - Exclusively on Amazon.com ASHLAND, Ore., Feb. 27, 2013 /PRNewswire/ -- NatureWise, the Amazon.com #1 best-selling manufacture of Green Coffee Bean Extract for the past six months is releasing its highly anticipated Raspberry Ketones weight loss supplement and appetite suppressant formula on Wednesday, February 27 with a huge 50% OFF 1-day only promotional sale. (Photo:...
Sales of Core Products Sucralose, Aspartame, Folic Acid and TGIC increase 18% CHINO, Calif., Feb. 26, 2013 /PRNewswire/ -- Niutang Chemical, the leading producer of Sucralose and Aspartame from China, announced today that demand for its core products of Sucralose, Aspartame, Folic Acid and TGIC remained high throughout 2012, resulting in an 18% increase in sales for the company. Niutang also announced that its new, 1200 metric ton capacity, state-of-the-art Sucralose facility...
SAN FRANCISCO, Feb. 26, 2013 /PRNewswire/ -- AstraZeneca today announced high-level results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of naloxegol versus usual care (UC) in patients with non-cancer related pain and opioid-induced constipation (OIC). UC was defined as the investigator's choice of an existing laxative treatment regimen for OIC. This is the fourth trial in the naloxegol Phase III development programme, and was designed to evaluate the...
WAYNE, N.J. and SOUTH SAN FRANCISCO, Calif., Feb. 25, 2013 /PRNewswire/ -- Intended for U.S. Media Only -- Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the U.S. Food and Drug Administration (FDA) approved Bayer's Stivarga(®) (regorafenib) tablets to treat patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.(1 )Stivarga...
RICHMOND, Va., Feb. 25, 2013 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals Inc. (RBP) announces that the U.S. Food and Drug Administration (FDA) has denied a Citizen's Petition filed by the Company. In the Citizen's Petition, RBP presented a new evaluation of pediatric exposure data and recommended that the FDA adopt more stringent packaging standards and increased educational interventions to help reduce the number of children exposed to buprenorphine-containing products...
April Flowers for redOrbit.com - Your Universe Online The Food and Drug Administration (FDA) has approved a brand new type of breast cancer medication this week that targets tumor cells while sparing healthy surrounding tissues. In U.S. women, breast cancer is the second most deadly form of cancer and is expected to kill more than 39,000 Americans this year alone, the National Cancer Institute reports. Kadcyla, from Roche, is a combination of a powerful chemotherapy drug, the...
OTTAWA, Feb. 22, 2013 /CNW/ - The issue: Two unauthorized health products "18 Again" and "Stiff 4 Hours" were tested by Health Canada and were found to contain hidden ingredients (sildenafil or tadalafil) that may pose serious risks to the health of Canadians. The products were being sold at the Unchained Romance booth at the 12(th) Annual Vancouver Taboo Sex Show. These products are promoted as male sexual stimulants and contain hidden prescription medications. Approved...
CUPERTINO, Calif., Feb. 22, 2013 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2012 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, February 28, 2013 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's...
Connie K. Ho for redOrbit.com – Your Universe Online Researchers from the U.S. Centers for Disease Control and Prevention (CDC) recently published a research letter highlighting the increase in deaths related to drug overdoses. In that report, researchers also explain that 2010 was the 11th consecutive year where a rise in deaths was seen. The analysis by the CDC demonstrated that 38,329 people died due to a drug overdose in the United States in 2010. The continuous rise in deaths...
Latest Organic chemistry Reference Libraries
Organometallics is a peer-reviewed scientific journal published by the American Chemical Society. As of May 2012, the editor-in-chief is John A. Gladysz. Organometallics publishes records in one of the most active fields for organometallic, inorganic, organic, and materials chemists. Articles, communications, mini-reviews, and notes detail the synthesis, structure, bonding, chemical reactivity and reaction mechanisms, and applications of organometallic and organometalloidal compounds....
Synthetic Metals is a peer-reviewed scientific journal published by Elsevier. It covers all aspects of electronic polymers and electronic molecular materials. It is an international medium for the rapid publication of original research papers, short communications and subject reviews dealing with research on and applications of electronic polymers and electronic molecular materials including novel carbon architectures. Original manuscripts on chemical, electrochemical, electrical, photonic...
